although in vivo therapy with brm or adoptive immunotherapy with brm-treated cells seems logical in the treatment of bronchogenic carcinoma , recent studies have shown that lymphocytes from the lung and tumor tissues of patients with bronchogenic carcinoma have defective cytotoxic function .
C0024109
lung
C0007121
bronchogenic carcinoma